Androgen receptor signalling in prostate: Effects of stromal factors on normal and cancer stem cells

Molecular and Cellular Endocrinology

Volumn 288, Issue 1-2, 2008, Pages 30-37

  Berry, Paul A ^a   Maitland, Norman J ^a   Collins, Anne T ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Androgen; Paracrine growth factors (stroma); Prostate (cancer stem cell)

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; CAVEOLIN 1; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 6; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ARTICLE; BINDING SITE; CANCER GROWTH; CANCER STEM CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE HYPERTROPHY; SIGNAL TRANSDUCTION; STROMA;

ANIMALS; HUMANS; MALE; MUTATION; NEOPLASTIC STEM CELLS; PROSTATE; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; STROMAL CELLS;

EID: 44649098788     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.02.024     Document Type: Article

References (93)

1. Antonioli E., Cardoso A.B., and Carvalho H.F. Effects of long-term castration on the smooth muscle cell phenotype of the rat ventral prostate. J. Androl. 28 (2007) 777-783
2. Ayala G., Tuxhorn J.A., Wheeler T.M., Frolov A., Scardino P.T., Ohori M., Wheeler M., Spitler J., and Rowley D.R. Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer. Clin. Cancer Res. 9 (2003) 4792-4801
3. Berry P.A., Maitland N.J., and Collins A.T. The role of androgen signalling in the regulation of human prostate epithelial stem cell differentiation. Prostate Cancer Prostatic Dis. 9 (2006) 360-361
4. Bolton E.C., So A.Y., Chiavorapol C., Haqq C.M., Li H., and Yamamoto K.R. Cell-and gene-specific regulation of primary target genes by the androgen receptor. Genes Dev. 21 (2007) 2005-2017
5. Bonaccorsi L., Muratori M., Carloni V., Marchiani S., Formigli L., Forti G., and Baldi E. The androgen receptor associates with the epidermal growth factor receptor in androgen-sensitive prostate cancer cells. Steroids 69 (2004) 549-552
6. Bonkhoff H., and Remberger K.D. Differentiation pathways and histogenetic aspects of normal and abnormal prostate growth: a stem cell model. Prostate 28 (1996) 98-106
7. Brennen N., Aggarwal S., Cole T., and Denmeade S.R. Fibroblast activation protein: targeting the reactive tumor stroma. AACR Innovation in Prostate Cancer Research Meeting. San Francisco (December 2006)
8. Bui M., and Reiter R.E. Stem cell genes in androgen-independent prostate cancer. Cancer Metastasis Rev. 17 (1999) 391-399
9. Cancer Research UK website/news & resources/UK cancer incidence statistics.
10. Cano P., Godoy A., Escamilla R., Dhir R., and Onate S.A. Stromal-epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer. Cancer Res. 67 (2007) 511-519
11. Chen S.-J., Karan D., Johansson S.L., Lin F.-F., Zeckser J., Singh A.P., Batra S.K., and Lin M.-F. Prostate-derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor-positive human prostate cancer cells. Prostate 67 (2007) 557-571
12. Cho K.S., Kim J., Choi Y.D., Kim J.H., and Hong S.J. The overlooked cause of benign prostatic hyperplasia: prostatic urethral angulation. Med. Hypotheses 70 (2007) 532-535
13. Chung L.W.K., Hsieh C.-L., Law A., Sung S.-Y., Gardner T.A., Egawa M., Matsubara S., and Zhau H.E. New targets for therapy in prostate cancer: modulation of stromal-epithelial interactions. Urology 62 (2003) 44-54
14. Chung L.W.K., Huang W.-C., Sung S.-Y., Wu D., Odero-Marah V., Nomura T., Shigemura K., Miyagi T., Seo S., Shi C., Molitierno J., Elmore J., Anderson C., Isotani S., Edlund M., Hsieh C.-L., Wang R., Shehata B., and Zhau H.E. Stromal-epithelial interaction in prostate cancer progression. Clin. Genitourinary Cancer 5 (2006) 162-170
15. Collins A.T., and Maitland N.J. Prostate cancer stem cells. Eur. J. Cancer 42 (2006) 1213-1218
16. Collins A.T., Zhiming B., Gilmore K., and Neal D.E. Androgen and oestrogen responsiveness of stromal cells derived from the human hyperplastic prostate: oestrogen regulation of the androgen receptor. J. Endocrinol. 143 (1994) 269-277
17. Collins A.T., Robinson E.J., and Neal D.E. Benign prostatic stromal cells are regulated by basic fibroblast growth factor and transforming growth factor-β1. J. Endocrinol. 151 (1996) 315-322
18. Collins A.T., Berry P.A., Hyde C., Stower M.J., and Maitland N.J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65 (2005) 10946-10951
19. Culig Z., Bartsch G., and Hobisch A. Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth. Mol. Cell. Endocrinol. 197 (2002) 231-238
20. Culig Z., Comuzzi B., Steiner H., Bartsch G., and Hobisch A. Expression and function of androgen receptor coactivators in prostate cancer. J. Steroid Biochem. Mol. Biol. 92 (2004) 265-271
21. Cunha G.R., Hayward S.W., Wang Y.Z., and Ricke W.A. Role of the stromal microenvironment in carcinogenesis of the prostate. Int. J. Cancer 107 (2003) 1-10
22. Dallas S.L., Zhao S., Cramer S.D., Chen Z., Peehl D.M., and Bonewald L.F. Preferential production of latent transforming growth factor β-2 by primary prostatic epithelial cells and its activation by prostate-specific antigen. J. Cell. Physiol. 202 (2005) 361-370
23. Danielpour D. Functions and regulation of transforming growth factor-beta (TGF-β) in the prostate. EJCa 41 (2005) 846-857
24. De Wever O., and Mareel M. Role of tissue stroma in cancer cell invasion. J. Pathol. 200 (2003) 429-447
25. Du Z., Fujiyama C., Chen Y., and Masaki Z. Expression of hypoxia-inducible factor 1 alpha in human normal, benign, and malignant prostate tissue. Chin. Med. J. (Engl.) 116 (2003) 1936-1939
26. Edwards J., Krishna N.S., Grigor K.M., and Bartlett J.M. Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer. Br. J. Cancer 89 (2003) 552-556
27. Etheridge S.L., Spencer G.J., Heath D.J., and Genever P.G. Expression profiling and functional analysis of Wnt signaling mechanisms in mesenchymal stem cells. Stem Cells 22 (2004) 849-860
28. Festuccia C., Angelucci A., Luca Gravina G., Biordi L., Millimaggi D., Muzi P., Vicentini C., and Bologna M. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. Thromb. Haemost. 93 (2005) 964-975
29. Freeman M.R., Cinar B., and Lu M.L. Membrane rafts as potential sites of nongenomic hormonal signaling in prostate cancer. Trends Endocrinol. Metab. 16 (2005) 273-279
30. Gerdes M.J., Larsen M., Dang T.D., Ressler S.J., Tuxhorn J.A., and Rowley D.R. Regulation of rat prostate stromal cell myodifferentiation by androgen and TGF-β1. Prostate 58 (2004) 299-307
31. Gingrich J.R., Barrios R.J., Morton R.A., Boyce B.F., DeMayo F.J., Finegold M.J., Angelopoulou R., Rosen J.M., and Greenberg N.M. Metastatic prostate cancer in a transgenic mouse. Cancer Res. 56 (1996) 4096-4102
32. Giri D., Ropiquet F., and Ittmann M. FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells. J. Cell Physiol. 180 (1999) 53-60
33. Gnanapragasam V.J., Robson C.N., Neal D.E., and Leung H.Y. Regulation of FGF8 expression by the androgen receptor in human prostate cancer. Oncogene 21 (2002) 5069-5080
34. Goo Y.A., Goodlett D.R., Pascal L.E., Worthington K.D., Vessella R.L., True L.D., and Liu A.Y. Stromal mesenchyme cell genes of the human prostate and bladder. BMC Urol. 5 (2005) 17-28
35. Grossfeld G.D., Hayward S.W., Tlsty T.D., and Cunha G.R. The role of stroma in prostatic carcinogenesis. Endocr. Relat. Cancer 5 (1998) 253-270
36. Grossmann M.E., Huang H., and Tindall D.J. Androgen receptor signaling in androgen-refractory prostate cancer. J. Natl. Cancer Inst. 93 (2001) 1687-1697
37. Halkidou K., Gnanapragasam V.J., Mehta P.B., Logan I.R., Brady M.E., Cook S., Leung H.Y., Neal D.E., and Robson C.N. Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development. Oncogene 22 (2003) 2466-2477
38. Hanson J.A., Gillespie J.W., Grover A., Tangrea M.A., Chuaqui R.F., Emmert-Buck M.R., Tangrea J.A., Libutti S.K., Linehan M., and Woodson K.G. Gene promoter methylation in prostate tumor-associated stromal cells. J. Natl. Cancer Inst. 98 (2006) 255-261
39. 1 integrin function and promotes differentiation of the transient amplifying population in human prostatic epithelium. J. Cell Sci. 119 (2006) 1416-1424
40. Heinlein C.A., and Chang C. Androgen receptor in prostate cancer. Endocr. Rev. 25 (2004) 276-308
41. Heitzer M.D., and DeFranco D.B. Hic-5/ARA55 a prostate stroma-specific AR coactivator. Steroids 72 (2007) 218-220
42. Heldin C.-H., Eriksson U., and Östman A. New members of the platelet-derived growth factor family of mitogens. Arch. Biochem. Biophys. 398 (2002) 284-290
43. Hill R., Song Y., Cardiff R.D., and van Dyke T. Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumourigenesis. Cell 123 (2005) 1001-1011
44. Hisataki T., Itoh N., Suzuki K., Takahashi A., Masumori N., Tohse N., Ohmori Y., Yamada S., and Tsukamoto T. Modulation of phenotype of human prostatic stromal cells by transforming growth factor-betas. The Prostate 58 (2004) 174-182
45. Holzbeierlein J., Lal P., LaTulippe E., Smith A., Satagopan J., Zhang L., Ryan C., Smith S., Scher H., Scardino P., Reuter V., and Gerald W.L. Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. Am. J. Pathol. 164 (2004) 217-227
46. Huang Y.-W., Wang L.-S., Chang H.-L., Ye W., Shu S., Sugimoto Y., and Lin Y.C. Effect of keratinocyte growth factor on cell viability in primary cultured human prostate cancer stromal cells. J. Steroid Biochem. Mol. Biol. 100 (2006) 24-33
47. Huss W.J., Gray D.R., Greenberg N.M., Mohler J.L., and Smith G.J. Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells. Cancer Res. 65 (2005) 6640-6650
48. Joesting M.S., Perrin S., Elenbaas B., Fawell S.E., Rubin J.S., Franco O.E., Hayward S.W., Cunha G.R., and Marker P.C. Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer. Cancer Res. 65 (2005) 10423-10430
49. Kang Z., Jänne O.A., and Palvimo J.J. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. Mol. Endocrinol. 18 (2004) 2633-2648
50. Kimbro K.S., and Simons J.W. Hypoxia-inducible factor-1 in human breast and prostate cancer. Endocr. Relat. Cancer 13 (2006) 739-749
51. Kwabi-Addo B., Ozen M., and Ittmann M. The role of fibroblast growth factors and their receptors in prostate cancer. Endocr. Relat. Cancer 11 (2004) 709-724
52. Levine A.C., Liu X.-H., Greenberg P.D., Eliashvili M., Schiff J.D., Aaronson S.A., Holland J.F., and Kirschenbaum A. Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts. Endocrinology 139 (1998) 4672-4678
53. Linja M.J., and Visakorpi T. Alterations of androgen receptor in prostate cancer. J. Steroid Biochem. Mol. Biol. 92 (2004) 255-264
54. Lu M.L., Schneider M.C., Zheng Y., Zhang X., and Richie J.P. Caveolin-1 interacts with androgen receptor. J. Biol. Chem. 276 (2001) 13442-13451
55. Lu T., Burdelya L.G., Swiatkowski S.M., Boiko A.D., Howe P.H., Stark G.R., and Gudkov A.V. Secreted transforming growth factor beta2 activates NF-kappa B, blocks apoptosis, and is essential for the survival of some tumor cells. PNAS 101 (2004) 7112-7117
56. Macintosh C.A., Stower M.J., Reid N., and Maitland N.J. Precise microdissection of human prostate cancers reveals genotypic heterogeneity. Cancer Res. 58 (1998) 23-28
57. Maeda A., Nakashiro K.-I., Hara S., Sasaki T., Miwa Y., Tanji N., Yokoyama M., Hamakawa H., and Oyasu R. Inactivation of AR activates HGF/c-Met system in human prostatic carcinoma cells. Biochem. Biophys. Res. Commun. 347 (2006) 1158-1165
58. Manji S.S., Parker N.J., Williams R.T., van Stekelenberg L., Pearson R.B., Dziadek M., and Smith P.J. STIM1: a novel phosphoprotein located at the cell surface. Biochim. Biophys. Acta 1481 (2000) 147-155
59. Massie C.E., Adryan B., Barbosa-Morais N.L., Lynch A.G., Tran M.G., Neal D.E., and Mills I.G. New androgen receptor genomic targets show an interaction with the ETS1 transcription factor. EMBO Rep. 8 (2007) 871-878
60. Mersmann M., Schmidt A., Rippmann J.F., Wüest T., Brocks B., Rettig W.J., Garin-Chesa P., Pfizenmaier K., and Moosmayer D. Human antibody derivatives against the fibroblast activation protein for tumour stroma targeting of carcinomas. Int. J. Cancer 92 (2001) 240-248
61. Micke P., and Östman A. Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?. Lung Cancer 45S2 (2004) S163-S175
62. Moinfar F., Man Y.G., Arnould L., Bratthauer G.L., Ratschek M., and Tavassoli F.A. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res. 60 (2000) 2562-2566
63. Nelson E.C., Cambio A.J., Yang J.C., Ok J.-H., Lara Jr. P.N., and Evans C.P. Clinical implications of neuroendocrine differentiation in prostate cancer. Prostate Cancer Prostatic Dis. 10 (2007) 6-14
64. Ohlson N., Bergh A., Stattin P., and Wikström P. Castration-induced epithelial cell death in human prostate tissue is related to locally reduced IGF-1 levels. Prostate 67 (2007) 32-40
65. Oosterhoff J.K., Grootegoed J.A., and Blok L.J. Expression profiling of androgen-dependent and -independent LNCaP cells: EGF versus androgen signalling. Endocr. Relat. Cancer 12 (2005) 135-148
66. Paterson R.F., Ulbright T.M., MacLennan G.T., Zhang S., Pan C.-X., Sweeney C.J., Moore C.R., Foster R.S., Koch M.O., Eble J.N., and Cheng L. Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma. Cancer 98 (2003) 1830-1836
67. Peehl D.M., and Rubin J.S. Keratinocyte growth factor: an androgen-regulated mediator of stromal-epithelial interactions in the prostate. World J. Urol. 13 (1995) 312-317
68. Ricciardelli C., Choong C.S., Buchanan G., Vivekanandan S., Neufing P., Stahl J., Marshall V.R., Horsfall D.J., and Tilley W.D. Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined disease. Prostate 63 (2005) 19-28
69. Richardson G.D., Robson C.N., Lang S.H., Neal D.E., Maitland N.J., and Collins A.T. CD133, a novel marker for human prostatic epithelial stem cells. J. Cell Sci. 117 (2004) 3539-3545
70. Riegman P.H.J., Vlietstra R.J., van der Korput J.A.G.M., Brinkmann A.O., and Trapman J. The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol. Endocrinol. 5 (1991) 1921-1930
71. Rizzo S., Attard G., and Hudson D.L. Prostate epithelial stem cells. Cell Prolif. 38 (2005) 363-374
72. Ruscica M., Dozio E., Motta M., and Magni P. Role of neuropeptide Y and its receptors in the progression of endocrine-related cancer. Peptides 28 (2007) 426-434
73. Savinainen K.J., Saramäki O.R., Linja M.J., Bratt O., Tammela T.L.J., Isola J.J., and Visakorpi T. Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer. Am. J. Pathol. 160 (2002) 339-345
74. Schalken J.A., and van Leenders G. Cellular and molecular biology of the prostate: stem cell biology. Urology 62 5 (Suppl. 1) (2003) 11-20
75. Schatzl G., Madersbacher S., Gsur A., Preyer M., Haidinger G., Haitel A., Vutuc C., Micksche M., and Marberger M. Association of polymorphisms within androgen receptor, 5α-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men. Prostate 52 (2002) 130-138
76. Setlur S.R., and Rubin M.A. Current thoughts on the role of the androgen receptor and prostate cancer progression. Adv. Anat. Pathol. 12 (2005) 265-270
77. Shang Y., Myers M., and Brown M. Formation of the androgen receptor transcription complex. Mol. Cell 9 (2002) 601-610
78. Sirotnak F.M., She Y., Khokhar N.Z., Hayes P., Gerald W., and Scher H.I. Microaaray analysis of prostate cancer progression to reduced androgen dependence: Studies in unique models contrasts early and late molecular events. Mol. Carcinog. 41 (2004) 150-163
79. Stuart R.O., Wachsman W., Berry C.C., Wang-Rodriguez J., Wasserman L., Klacansky I., Masys D., Arden K., Goodison S., McClelland M., Wang Y., Sawyers A., Kalcheva I., Tarin D., and Mercola D. In silico dissection of cell-type-associated patterns of gene expression in prostate cancer. PNAS 101 (2004) 615-620
80. Suyama E., Wadhwa R., Kaur K., Miyagishi M., Kaul S.C., Kawasaki H., and Taira K. Identification of metastasis-related genes in a mouse model using a library of randomized ribozymes. J. Biol. Chem. 279 (2004) 38083-38086
81. Takayama K., Kaneshiro K., Tsutsumi S., Horie-Inoue K., Ikeda K., Urano T., Ijichi N., Ouchi Y., Shirahige K., Aburatani H., and Inoue S. Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis. Oncogene 26 (2007) 4453-4463
82. Tate A., Isotani S., Bradley M.J., Sikes R.A., Davis R., Chung L.W.K., and Edlund M. Met-independent hepatocyte growth factor-mediated regulation of cell adhesion in human prostate cancer cells. BMC Cancer 6 (2006) 197-212
83. Thomson A.A., and Cunha G.R. Prostatic growth and development are regulated by FGF10. Development 126 (1999) 3693-3701
84. Tokunou M., Niki T., Eguchi K., Iba S., Tsuda H., Yamada T., Matsuno Y., Kondo T., Saitoh Y., Imamura H., and Hirohashi S. c-MET expression in myofibroblasts role in autocrine activation and prognostic significance in lung adenocarcinoma. Am. J. Pathol. 158 (2001) 1451-1463
85. Tuxhorn J.A., Ayala G.E., Smith M.J., Smith V.C., Dang T.D., and Rowley D.R. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin. Cancer Res. 8 (2002) 2912-2923
86. Veldscholte J., Ris-Stalpers C., Kuiper G.G., Jenster G., Berrevoets C., Claassen E., van Rooij H.C., Trapman J., Brinkmann A.O., and Mulder E. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem. Biophys. Res. Commun. 173 (1990) 534-540
87. Verras M., Lee J., Xue H., Li T.-H., Wang Y., and Sun Z. The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression. Cancer Res. 67 (2007) 967-975
88. Wang Q., Carroll J.S., and Brown M. Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol. Cell 19 (2005) 631-642
89. Wang G., Jones S.J.M., Marra M.A., and Sadar M.D. Identification of genes targeted by the androgen and PKA signaling pathways in prostate cancer cells. Oncogene 25 (2006) 7311-7323
90. Wang Q., Li W., Liu X.S., Carroll J.S., Jänne O.A., Krasnickas Keeton E., Chinnaiyan A.M., Pienta K.J., and Brown M. A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol. Cell 27 (2007) 380-392
91. Yang G., Truong L.D., Timme T.L., Ren C., Wheeler T.M., Park S.H., Nasu Y., Bangma C.H., Kattan M.W., Scardino P.T., and Thompson T.C. Elevated expression of caveolin is associated with prostate and breast cancer. Clin. Cancer Res. 4 (1998) 1873-1880
92. York T.P., Plymate S.R., Nelson P.S., Eaves L.J., Webb H.D., and Ware J.L. cDNA microarray analysis identifies genes induced in common by peptide growth factors and androgen in human prostate epithelial cells. Mol. Carcinog. 44 (2005) 242-251
93. Zhao H., Shiina H., Greene K.L., Li L.-C., Tanaka Y., Kishi H., Igawa M., Kane C.J., Carroll P., and Dahiya R. CpG methylation at promoter site-140 inactivates TGFβ2 receptor gene in prostate cancer. Cancer 104 (2005) 44-52